ESR1 and breast carcinoma: MYC is upregulated by estrogen receptor in ERα positive breast cancer cells, through binding to an enhancer located 67 kb upstream of the transcription start site [199,200,201], and ectopic expression of MYC in cells treated with ERα antagonists can rescue their proliferative defects [202].